Variations in the Risk of New‐Onset Diabetes Following COVID ‐19 Infection Across Body Mass Index, Deprivation, Ethnicity and Geographic Regions: Population‐Based Cohort Study in 42 Million People in England
Open Access
- 10 May 2026
- journal article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (8) , 6661-6673
Abstract
Aims: Evidence suggests that COVID‐19 may be associated with an increased risk of diabetes. We aimed to examine this association by investigating the role of socioeconomic and metabolic factors on the risk of new‐onset type 2 (T2D) and type 1 (T1D) diabetes after COVID‐19 diagnosis. Materials and Methods: We conducted a retrospective, population‐based cohort study using linked electronic health records from NHS England's Secure Data Environment for England via the CVD‐COVID‐UK/COVID‐IMPACT consortium. Adults (≥ 18 years), alive, registered with a general practice within 1 January 2020 and 28 May 2024 were included. Exposed individuals with confirmed COVID‐19 diagnosis and no prior diabetes were matched to up to three unexposed individuals without COVID‐19 and diabetes on age, sex, region and deprivation. Flexible parametric survival models were used to estimate associations between COVID‐19 and incident diabetes by sex and across age, BMI, deprivation, ethnicity, and region. Results: Of 50 156 810 eligible individuals, 12 859 545 with a COVID‐19 diagnosis and no prior diabetes were matched to 29 221 285 without COVID‐19; the median follow‐up was 2.4 years. Although BMI was strongly and positively associated with the risk of T2D, differences between exposed and unexposed individuals were little to none, with the excess risk concentrated in the first year (e.g., in 70‐year‐old men with BMI 35 kg/m 2 , rates were 44.2 [95% CI: 43.6–44.8] and 44.2 [43.7–44.8] per 1000 person‐years in the exposed and unexposed group, respectively, at 1 year; corresponding figures in women were 28.0 [27.6–28.5] and 29.1 [28.7–29.5]). These rate differences by COVID‐19 exposure were considerably smaller than those across BMI levels: for example, 22 more T2D cases per 1000 person‐years at 1 year for those with a BMI of 35 versus 30 kg/m 2 in unexposed 70‐year‐old men. Similarly, higher deprivation and Asian ethnicity were also more strongly associated with the risk of T2D than COVID‐19 exposure. There was no evidence of an association between COVID‐19 and T1D across all analyses. Conclusions: In this cohort, COVID‐19 was associated with a modest, short‐term increase in T2D risk and showed no meaningful association with T1D. Established metabolic, demographic and socioeconomic factors—including age, BMI, deprivation and ethnicity—were more strongly associated with T2D incidence than COVID‐19 exposure.Keywords
Funding Information
- National Institute for Health and Care Research
This publication has 29 references indexed in Scilit:
- Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million peopleThe Lancet Diabetes & Endocrinology, 2024
- Undiagnosed type 2 diabetes: an invisible risk factorThe Lancet Diabetes & Endocrinology, 2024
- Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort studyThe Lancet Infectious Diseases, 2023
- Incidence of Diabetes in Children and Adolescents During the COVID-19 PandemicJAMA Network Open, 2023
- Association between glycemic control and the outcome in hospitalized patients with COVID-19Endocrine, 2022
- Risks and burdens of incident diabetes in long COVID: a cohort studyThe Lancet Diabetes & Endocrinology, 2022
- Disparities in COVID-19 Outcomes by Race, Ethnicity, and Socioeconomic StatusJAMA Network Open, 2021
- Socioeconomic deprivation and genetic ancestry interact to modify type 2 diabetes ethnic disparities in the United KingdomeClinicalMedicine, 2021
- Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort studyThe Lancet Diabetes & Endocrinology, 2021
- Testing at scale during the COVID-19 pandemicNature Reviews Genetics, 2021